William Blair Has Optimistic Outlook of NKTR Q1 Earnings
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at William Blair raised their Q1 2025 EPS estimates for Nektar Therapeutics in a research report issued to clients and investors on Thursday, March 13th. William Blair analyst A. Hsieh now anticipates that the biopharmaceutical company will post earnings of ($0.19) per share for the quarter, up […]
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at William Blair raised their Q1 2025 EPS estimates for Nektar Therapeutics in a research report issued to clients and investors on Thursday, March 13th. William Blair analyst A. Hsieh now anticipates that the biopharmaceutical company will post earnings of ($0.19) per share for the quarter, up […]
